Natera
Bernie Tobin is a 25-year veteran of the healthcare industry with his most recent role serving as President of Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics. Crescendo focused on using proteomics to deliver precision medicine to patients with autoimmune disorders.
Previously, Mr. Tobin held several senior-level positions at Amgen including General Manager of both the Netherlands and Brazil and Global Head of Commercial Excellence. In addition, he led the global integration of a business development acquisition in over 100 countries. Prior to that, Mr. Tobin held a variety of leadership roles in the commercial organization at Eli Lilly and Co. He received his B.S. degree in Public Service and Administration from Iowa State University and his M.B.A. from the Fuqua School of Business, Duke University.
This person is not in any teams
This person is not in any offices
Natera
25 followers
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology. Where some set out to build a test, they set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.